Insider Transactions in Q3 2022 at Hcw Biologics Inc. (HCWB)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 14
2022
|
Rebecca Byam Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
15,000
+4.37%
|
$30,000
$2.58 P/Share
|
|
Sep 13
2022
|
Rebecca Byam Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
15,000
+4.57%
|
$30,000
$2.58 P/Share
|
|
Sep 12
2022
|
Rebecca Byam Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
15,000
+4.79%
|
$30,000
$2.65 P/Share
|
|
Sep 09
2022
|
Hing C Wong Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
6,000
+0.04%
|
$12,000
$2.7 P/Share
|
|
Sep 08
2022
|
Hing C Wong Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
4,000
+0.03%
|
$8,000
$2.67 P/Share
|
|
Sep 07
2022
|
Hing C Wong Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
6,000
+0.04%
|
$12,000
$2.58 P/Share
|
|
Sep 02
2022
|
Hing C Wong Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
4,000
+0.03%
|
$8,000
$2.55 P/Share
|
|
Aug 31
2022
|
Rebecca Byam Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+3.41%
|
$20,000
$2.56 P/Share
|
|
Aug 30
2022
|
Rebecca Byam Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
7,200
+2.57%
|
$14,400
$2.55 P/Share
|
|
Aug 29
2022
|
Rebecca Byam Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+3.63%
|
$20,000
$2.57 P/Share
|
|
Aug 26
2022
|
Rebecca Byam Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+3.76%
|
$20,000
$2.54 P/Share
|
|
Aug 25
2022
|
Rebecca Byam Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
40,300
+14.09%
|
$80,600
$2.59 P/Share
|
|
Aug 24
2022
|
Rebecca Byam Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
50,000
+19.57%
|
$100,000
$2.5 P/Share
|